- Status:
- Grey - after consultant/specialist initiation
- Decision Date:
- March 2017
Comments
GREY after consultant/specialist initiation: for hypersalivation (sialorrhoea) or drooling after a trial or consideration of hyoscine (oral and patches).
- For children: Glycopyrronium (Sialanar) is the preferred product for hypersalivation in children with chronic neurological conditions (licenced for children and adolescents aged 3 years and over). For short term intermittent use, but may be continued for long term use after assessment from the specialist.
- For adults: Assicco is the preferred cost effective brand (Decision date April 2024)
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
search again